DTC

Senators Chuck Grassley and Dick Durbin asked the Government Accountability Office (GAO) to review the relationship between…

The Federal Trade Commission (“FTC”) recently released its annual report for 2019. The FTC’s annual report details the FTC’s…

On June 16, 2020, a unanimous panel of the District of Columbia Circuit Court ruled that a rule finalized by the United States…

The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) announced a study of oncology…

The Federal Trade Commission (“FTC”) sent letters to several law firms and marketing companies, warning them that advertisements…

Following a review of pharmaceutical advertising, the UK’s Prescription Medicines Code of Practice Authority (“PMCPA”) cited…

The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) recently issued an enforcement letter…

The FDA’s Office of Prescription Drug Promotion (OPDP) issued its second untitled letter of the year to California drugmaker Vivus…

The US Food and Drug Administration (“FDA”) recently published a notice in the Federal Register seeking to find out more about how…

On June 14, 2019, several pharmaceutical companies filed suit against the Department of Health and Human Services (“HHS”), seeking…